Online citations, reference lists, and bibliographies.
← Back to Search

Radiogenomic Analysis Of Oncological Data: A Technical Survey

M. Incoronato, Marco Aiello, T. Infante, C. Cavaliere, A. Grimaldi, P. Mirabelli, S. Monti, M. Salvatore
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In the last few years, biomedical research has been boosted by the technological development of analytical instrumentation generating a large volume of data. Such information has increased in complexity from basic (i.e., blood samples) to extensive sets encompassing many aspects of a subject phenotype, and now rapidly extending into genetic and, more recently, radiomic information. Radiogenomics integrates both aspects, investigating the relationship between imaging features and gene expression. From a methodological point of view, radiogenomics takes advantage of non-conventional data analysis techniques that reveal meaningful information for decision-support in cancer diagnosis and treatment. This survey is aimed to review the state-of-the-art techniques employed in radiomics and genomics with special focus on analysis methods based on molecular and multimodal probes. The impact of single and combined techniques will be discussed in light of their suitability in correlation and predictive studies of specific oncologic diseases.
This paper references
10.1016/j.ejrad.2015.07.002
Breast cancer in very young women (<30 years): Correlation of imaging features with clinicopathological features and immunohistochemical subtypes.
Yeong Yi An (2015)
10.1038/nbt.1633
Ab initio reconstruction of transcriptomes of pluripotent and lineage committed cells reveals gene structures of thousands of lincRNAs
M. Guttman (2010)
10.1148/radiol.12111607
Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.
O. Gevaert (2012)
10.1117/1.JMI.2.4.041007
Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data
Wentian Guo (2015)
10.1007/s00234-015-1576-7
Somatic mutations associated with MRI-derived volumetric features in glioblastoma
D. Gutman (2015)
10.1148/radiol.2503081054
Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
T. Uematsu (2009)
10.1016/j.neuroimage.2010.01.042
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort
L. Shen (2010)
10.5334/OJB.26
SDN Biobank: Bioresource of Human Samples Associated with Functional and/or Morphological Bioimaging Results for the Study of Oncological, Cardiological, Neurological, and Metabolic Diseases
P. Mirabelli (2017)
10.1148/radiol.13122697
Quantitative imaging in cancer evolution and ecology.
R. Gatenby (2013)
10.1016/j.gene.2014.06.034
RNA-Seq for the identification of novel Mediator transcripts in endothelial progenitor cells.
Monica Rienzo (2014)
10.3171/2015.4.JNS142732
A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma.
A. Rao (2016)
10.1309/AJCPKP2QUVN4RCCP
Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma.
T. Elsheikh (2008)
10.1148/radiol.14132641
Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.
M. Mazurowski (2014)
10.1371/journal.pone.0102107
Robust Radiomics Feature Quantification Using Semiautomatic Volumetric Segmentation
Chintan Parmar (2014)
10.1093/bioinformatics/btu638
HTSeq—a Python framework to work with high-throughput sequencing data
S. Anders (2015)
10.1093/bioinformatics/btu077
SOAPdenovo-Trans: de novo transcriptome assembly with short RNA-Seq reads
Y. Xie (2014)
10.1016/j.acra.2010.08.021
CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool.
M. Nishino (2011)
10.1148/radiol.2015151169
Radiomics: Images Are More than Pictures, They Are Data
R. Gillies (2016)
10.1016/j.ebiom.2016.07.017
Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic Treatment
S. Mehta (2016)
10.1007/s10278-014-9716-x
Test–Retest Reproducibility Analysis of Lung CT Image Features
Yoganand Balagurunathan (2014)
10.21769/BIOPROTOC.777
DNA Methylation Profiling Using Infinium Methylation Assay
Constanze Zeller (2013)
10.1038/srep17787
Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma
Y. Zhu (2015)
10.1007/s12282-013-0512-0
Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer
K. Yamaguchi (2014)
10.2217/epi.15.21
Base resolution methylome profiling: considerations in platform selection, data preprocessing and analysis
Z. Sun (2015)
10.1093/neuonc/now121
Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas
B. Zhang (2017)
10.1016/0888-7543(92)90079-8
Report on the sequencing by hybridization workshop.
C. Cantor (1992)
10.1007/s11307-009-0294-0
Degree of Tumor FDG Uptake Correlates with Proliferation Index in Triple Negative Breast Cancer
J. Tchou (2009)
10.1016/J.JVIR.2007.04.031
Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma.
M. Kuo (2007)
10.1007/BF00204594
Gabor filters as texture discriminator
I. Fogel (2004)
10.1158/1078-0432.CCR-06-2772
Relationship between Survival and Edema in Malignant Gliomas: Role of Vascular Endothelial Growth Factor and Neuronal Pentraxin 2
Marc R. J. Carlson (2007)
10.1148/radiol.2491072000
Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis.
W. Pope (2008)
10.3109/0284186X.2010.498437
Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters
P. Galavis (2010)
10.1371/journal.pone.0164113
A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images
A. Forgacs (2016)
10.1007/978-3-319-23603-2_7
Mapping Transcription Regulatory Networks with ChIP-seq and RNA-seq.
J. Wade (2015)
Bioresource of human samples associated with functional and/or morphological bioimaging results for the study of oncological, cardiological, neurological, and metabolic diseases
P Mirabelli
10.1016/j.jacr.2015.10.013
Leveraging Imperfect Data Sets to Draw New Conclusions: Radiogenomics' True Value?
Li Yang (2016)
10.1007/s13244-012-0196-6
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
Fergus Davnall (2012)
10.1038/nbt.3122
StringTie enables improved reconstruction of a transcriptome from RNA-seq reads
M. Pertea (2015)
10.1016/j.radonc.2012.09.023
A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists' delineations and with the surgical specimen.
E. Rios Velazquez (2012)
10.1148/radiol.14131731
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
O. Gevaert (2014)
10.17226/13297
Evolution of Translational Omics: Lessons Learned and the Path Forward
Christine M Micheel (2013)
Objective image fusion performance
C. S. Xydeas (2000)
10.1007/s00330-017-4751-x
Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma
Y. Cui (2017)
10.1148/radiol.13130663
Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations.
C. Karlo (2014)
10.3174/ajnr.A2956
Correlation of Perfusion Parameters with Genes Related to Angiogenesis Regulation in Glioblastoma: A Feasibility Study
R. Jain (2012)
10.1093/bioinformatics/btu170
Trimmomatic: a flexible trimmer for Illumina sequence data
A. Bolger (2014)
10.1561/2000000039
Deep Learning: Methods and Applications
L. Deng (2014)
10.1007/978-1-4939-3136-1_12
DNA Microarray-Based Diagnostics.
Mahsa Gharibi Marzancola (2016)
10.1593/TLO.13730
Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.
M. Zhou (2014)
10.1016/j.eururo.2015.08.052
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.
J. Weinreb (2016)
10.1155/2010/853916
Uncovering the Complexity of Transcriptomes with RNA-Seq
V. Costa (2010)
10.1142/9789813235533_0028
IMAGING GENOMICS.
Heng Huang (2018)
10.1007/s11547-015-0527-z
MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index
C. Molinari (2015)
10.1016/j.radonc.2010.05.003
Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool.
Iris E van Dam (2010)
10.1158/1078-0432.CCR-14-0990
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
J. O'Connor (2014)
10.1056/NEJMp1606181
Predicting the Future - Big Data, Machine Learning, and Clinical Medicine.
Z. Obermeyer (2016)
10.1038/nbt.1633
Ab initio reconstruction of cell type–specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs
M. Guttman (2010)
10.1109/JPROC.2015.2494198
Machine Learning in Genomic Medicine: A Review of Computational Problems and Data Sets
M. Leung (2016)
10.1038/srep33860
Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC
H. Aerts (2016)
10.1177/0284185114524197
Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes
M. Bae (2015)
10.1093/bioinformatics/btp041
Genome-wide association analysis by lasso penalized logistic regression
T. Wu (2009)
10.1007/S12561-012-9069-2
Simultaneous Isoform Discovery and Quantification from RNA-Seq
D. Hiller (2013)
A revolutionary tool for transcriptomics
Z Wang (2009)
10.1093/bioinformatics/bts635
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin (2013)
10.3389/fonc.2016.00071
Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology
Weimiao Wu (2016)
Applications of next-generation sequencing sequencing technologies—The next generation
M. L. Metzker (2010)
F-18-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: Microarray and immunohistochemical analysis
J. R. Osborne (2010)
NF - κ B protein expression associates with F18FDG PET tumor uptake in non - small
V. S. Nair
10.1093/bioinformatics/bts094
Oases: robust de novo RNA-seq assembly across the dynamic range of expression levels
Marcel H. Schulz (2012)
10.1158/0008-5472.CAN-10-4633
18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.
Nicolaos Palaskas (2011)
10.3389/fnins.2016.00064
Hybrid PET/MR Imaging and Brain Connectivity
M. Aiello (2016)
10.1002/jmri.24879
Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms
L. Grimm (2015)
10.1101/SQB.1986.051.01.016
Molecular approaches to mammalian genetics.
A. Poustka (1986)
10.1101/gr.079558.108
RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays.
J. Marioni (2008)
10.1038/nprot.2013.084
De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis
B. Haas (2013)
10.1371/journal.pone.0025451
Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme
P. Zinn (2011)
10.1001/jamaoncol.2016.2631
The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review.
H. Aerts (2016)
10.1038/srep41674
Predictive radiogenomics modeling of EGFR mutation status in lung cancer
O. Gevaert (2017)
10.1038/nbt.1883
Full-length transcriptome assembly from RNA-Seq data without a reference genome.
M. Grabherr (2011)
10.2214/AJR.11.7824
Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape.
S. Yamamoto (2012)
10.1038/nbt.2122
Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome
Zhiyu Peng (2012)
10.1093/bioinformatics/btr355
Identification of novel transcripts in annotated genomes using RNA-Seq
Adam Roberts (2011)
10.1021/acsnano.5b00147
Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting.
Aaron C. Anselmo (2015)
On Bias , Variance , 0 / 1-Loss , and the Curse-of-Dimensionality
Weiqiang Dong (2014)
10.1186/1755-8794-7-30
Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project
R. Colen (2014)
10.1049/EL:20000267
Objective image fusion performance measure
C. Xydeas (2000)
10.1016/j.lungcan.2013.11.001
NF-κB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism.
V. Nair (2014)
10.1007/978-1-4939-7172-5_5
Principles and Methods of Immunohistochemistry.
J. Ramos-Vara (2017)
10.1038/srep13087
Machine Learning methods for Quantitative Radiomic Biomarkers
Chintan Parmar (2015)
10.1093/bioinformatics/bts503
Qualimap: evaluating next-generation sequencing alignment data
F. García-Alcalde (2012)
10.1038/nrg2484
RNA-Seq: a revolutionary tool for transcriptomics
Zhong Wang (2009)
Ultrafast universal RNA-seq aligner
A Dobin (2013)
Correlation between F-18-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer
H. R. Koo (2015)
10.1093/nar/gkl200
AUGUSTUS: ab initio prediction of alternative transcripts
M. Stanke (2006)
10.1038/nmeth.1223
Stem cell transcriptome profiling via massive-scale mRNA sequencing
N. Cloonan (2008)
10.18632/oncotarget.10523
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
R. Stoyanova (2016)
10.1109/TSMC.1973.4309314
Textural Features for Image Classification
R. Haralick (1973)
10.1093/bioinformatics/bts356
RSeQC: quality control of RNA-seq experiments
L. Wang (2012)
Информативность мультипараметрического МР-исследования в выявлении рака предстательной железы. Классификация pi-rads (prostate imaging-reporting and data system)
А. С. Коробкин (2015)
10.1093/neuonc/not008
Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images.
Kourosh M. Naeini (2013)
10.1038/nmeth.2714
Assessment of transcript reconstruction methods for RNA-seq
Tamara Steijger (2013)
10.1038/ng.259
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
Q. Pan (2008)
10.1016/j.neuroimage.2007.02.018
What is where and why it is important
A. Toga (2007)
10.1007/978-1-4939-2291-8_8
Quality control of RNA-seq experiments.
X. Li (2015)
Next-generation sequencing for cancer diagnostics: a practical perspective.
C. Meldrum (2011)
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license
Gallen international breast cancer conference 2013: Primary therapy of early breast cancer evidence, controversies, consensus-Opinion of a german team of experts
M Untch (2013)
10.1073/pnas.0801279105
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
M. Diehn (2008)
10.1016/j.ejrad.2016.02.017
Characterization of tumor and adjacent peritumoral stroma in patients with breast cancer using high-resolution diffusion-weighted imaging: Correlation with pathologic biomarkers.
H. J. Shin (2016)
10.1038/nmeth.2563
In situ sequencing for RNA analysis in preserved tissue and cells
Rongqin Ke (2013)
10.1148/radiol.13130078
Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.
N. Jamshidi (2014)
10.1093/neuonc/nos335
Imaging descriptors improve the predictive power of survival models for glioblastoma patients.
M. Mazurowski (2013)
10.1093/nar/gku489
Integrated RNA and DNA sequencing improves mutation detection in low purity tumors
M. Wilkerson (2014)
10.1371/journal.pone.0041522
A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature
P. Zinn (2012)
10.1148/RADIOL.2016161382
Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.
P. Kickingereder (2016)
State-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using PET. Front
T Carlier (2015)
10.1177/1971400916678225
Mesoscopic imaging of glioblastomas: Are diffusion, perfusion and spectroscopic measures influenced by the radiogenetic phenotype?
T. Demerath (2017)
10.1118/1.4957254
MO-DE-207B-05: Predicting Gene Mutations in Renal Cell Carcinoma Based On CT Imaging Features: Validation Using TCGA-TCIA Datasets.
Xuesong Chen (2016)
10.1016/j.radonc.2015.06.013
Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells.
K. M. Panth (2015)
10.1038/nbt1306
Decoding global gene expression programs in liver cancer by noninvasive imaging
E. Segal (2007)
10.1038/nmeth.2694
Quantitative assessment of single-cell RNA-sequencing methods
A. Wu (2014)
10.1093/neuonc/now135
Radiogenomics to characterize regional genetic heterogeneity in glioblastoma
L. Hu (2017)
10.1002/jmri.25119
Breast cancer molecular subtype classifier that incorporates MRI features
E. Sutton (2016)
10.1038/nrg2626
Sequencing technologies — the next generation
M. Metzker (2010)
10.1016/j.acra.2015.11.005
Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or Gefitinib.
M. Nishino (2016)
10.1002/wrna.1364
RNA‐Seq methods for transcriptome analysis
R. Hrdličková (2017)
10.1126/science.270.5235.467
Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
M. Schena (1995)
10.1007/s11060-011-0737-8
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy
W. Pope (2011)
10.1148/radiol.09090663
Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging.
R. Barajas (2010)
10.1038/nbt.2850
Genome-guided transcript assembly from integrative analysis of RNA sequence data
Nathan Boley (2014)
10.1016/j.jacr.2015.04.019
Radiogenomics: what it is and why it is important.
M. Mazurowski (2015)
10.1148/radiol.15142698
Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.
S. Yamamoto (2015)
10.18632/oncotarget.11522
Molecular differences between cerebral blood volume and vessel size in glioblastoma multiforme
D. Heiland (2017)
10.1016/j.mri.2012.06.010
Radiomics: the process and the challenges.
Virendra Kumar (2012)
10.1016/j.neurad.2014.02.006
Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients.
M. Nicolas-Jilwan (2015)
10.3389/fmed.2015.00018
State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET
T. Carlier (2015)
10.1148/radiol.13132195
Behind the numbers: Decoding molecular phenotypes with radiogenomics--guiding principles and technical considerations.
M. Kuo (2014)
10.1109/21.44046
Textural features corresponding to textural properties
Moses Amadasun (1989)
10.1186/s13059-016-0881-8
A survey of best practices for RNA-seq data analysis
Ana Conesa (2016)
10.1016/j.cell.2007.01.029
The Epigenomics of Cancer
P. Jones (2007)
10.1002/jmri.24890
Breast cancer subtype intertumor heterogeneity: MRI‐based features predict results of a genomic assay
E. Sutton (2015)
10.1586/14737159.2015.1105133
Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization
Monica Sager (2015)
10.1186/s13062-015-0077-2
Microarray experiments and factors which affect their reliability
R. Jaksik (2015)
10.1007/s00330-013-3037-1
18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes
H. R. Koo (2013)
10.3109/0284186X.2013.812798
Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability
R. Leijenaar (2013)
10.1186/gb-2011-12-1-r6
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
H. Edgren (2010)
10.1093/bioinformatics/btt656
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Y. Liao (2014)
10.1093/bioinformatics/btp324
Fast and accurate short read alignment with Burrows–Wheeler transform
Heng Li (2009)
10.1007/s00330-015-3734-z
Correlation between 18F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer
H. R. Koo (2015)
10.1016/j.amjsurg.2015.03.027
Distinct clinicopathological phenotype of hepatocellular carcinoma with ethoxybenzyl-magnetic resonance imaging hyperintensity: association with gene expression signature.
T. Miura (2015)
10.1016/S0146-664X(75)80008-6
Texture analysis using gray level run lengths
M. Galloway (1974)
10.1148/76.1.130a
[The American College of Radiology].
O. Linton (1992)
10.1148/radiol.2015150800
The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma.
N. Jamshidi (2015)
10.1259/bjr.20151030
Imaging genomics in cancer research: limitations and promises.
H. Bai (2016)
10.2967/jnumed.108.060459
18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis
J. Osborne (2010)
10.1373/clinchem.2008.112789
Next-generation sequencing: from basic research to diagnostics.
K. Voelkerding (2009)
10.1038/nmeth.1923
Fast gapped-read alignment with Bowtie 2
B. Langmead (2012)
10.1111/tbj.12182
MR Imaging Features of Triple‐Negative Breast Cancers
J. Sung (2013)
10.1038/NCOMMS5644
Corrigendum: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
H. Aerts (2014)
Imaging genomics. Br
A. R. Hariri (2003)
10.1101/gr.142232.112
iReckon: simultaneous isoform discovery and abundance estimation from RNA-seq data.
Aziz M. Mezlini (2013)
10.1016/j.ejca.2011.11.036
Radiomics: extracting more information from medical images using advanced feature analysis.
P. Lambin (2012)
10.1038/nmeth.1226
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Ali Mortazavi (2008)
10.1093/bioinformatics/btp579
Effect of read-mapping biases on detecting allele-specific expression from RNA-sequencing data
Jacob F. Degner (2009)
10.1093/mutage/geu031
Next-generation sequencing technologies: breaking the sound barrier of human genetics
E. M. Bahassi (2014)
10.1016/j.ejrad.2016.02.015
Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma.
K. Kitajima (2016)
10.1038/nmeth.2722
Systematic evaluation of spliced alignment programs for RNA-seq data
P. Engström (2013)
10.1159/000351692
13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013)
M. Untch (2013)
10.2214/AJR.15.14967
Quantitative Multiparametric MRI Features and PTEN Expression of Peripheral Zone Prostate Cancer: A Pilot Study.
Stephanie McCann (2016)
10.1007/s00261-015-0386-z
Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas–Renal Cell Carcinoma (TCGA–RCC) Imaging Research Group
A. Shinagare (2015)
10.1016/j.ejrad.2014.09.015
Correlation between 3T apparent diffusion coefficient values and grading of invasive breast carcinoma.
V. Cipolla (2014)



This paper is referenced by
10.1186/s12967-019-2073-2
Bringing radiomics into a multi-omics framework for a comprehensive genotype–phenotype characterization of oncological diseases
Mario Zanfardino (2019)
10.1155/2018/5076269
DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes
S. Monti (2018)
10.1155/2019/1071453
MR Imaging-Histology Correlation by Tailored 3D-Printed Slicer in Oncological Assessment
D. Baldi (2019)
10.1259/bjro.20190046
Radiomics for radiation oncologists: are we ready to go?
Loïg Vaugier (2020)
10.1007/s13246-019-00730-z
Multiparametric MRI and radiomics in prostate cancer: a review
Y. Sun (2019)
10.3390/cancers11091293
A Radiogenomic Approach for Decoding Molecular Mechanisms Underlying Tumor Progression in Prostate Cancer
S. Fischer (2019)
10.25040/ECPB2017.04.005
Assessment of Skeletal Muscle Strength, Fatigue and Respiratory Efficiency in Young Healthy Females during Different Phases of Menstrual Cycle
Udayakumar Karthika Priyadharshini (2017)
10.1007/S11071-018-04737-1
Controlling and stabilizing unpredictable behavior of metabolic reactions and carcinogenesis in biological systems
Larysa Dzyubak (2019)
10.1007/978-3-030-31171-1_13
Radiomics and Imaging Genomics for Evaluation of Tumor Response
G. Lee (2020)
10.1007/s00330-019-6004-7
Differentiating kidney stones from phleboliths in unenhanced low-dose computed tomography using radiomics and machine learning
T. De Perrot (2019)
10.1007/978-3-319-94878-2_14
Deep Learning in Breast Cancer Screening
Hugh Harvey (2019)
10.3348/kjr.2019.0630
Radiomics in Lung Cancer from Basic to Advanced: Current Status and Future Directions
G. Lee (2020)
10.1017/S1460396918000547
A review of radiation genomics: integrating patient radiation response with genomics for personalised and targeted radiation therapy
Lu Xu (2019)
10.3390/jcm8030316
The Challenges of Diagnostic Imaging in the Era of Big Data
M. Aiello (2019)
10.1111/1759-7714.13163
Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT‐based radiomics signature
Xiao-xiao Wang (2019)
10.21147/j.issn.1000-9604.2019.05.10
Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study
Z. Ye (2019)
10.3390/cancers12020390
Multiparametric MRI for Prostate Cancer Detection: New Insights into the Combined Use of a Radiomic Approach with Advanced Acquisition Protocol
S. Monti (2020)
10.1186/s40644-020-0296-3
Resectable pancreatic ductal adenocarcinoma: association between preoperative CT texture features and metastatic nodal involvement
Wei Fang (2020)
10.25040/ECPB2017.04.009
Radiogenomics of Renal Cell Carcinoma: Our Clinical Experience
Yu.O. Mytsyk (2017)
10.1109/CACIDI.2018.8584357
Development of a graphic interface for the three-dimensional semiautomatic glioblastoma segmentation based on magnetic resonance images
Alexander Mulet de los Reyes (2018)
10.14288/1.0389786
Volumetric image-based supervised learning approaches for kidney cancer detection and analysis
M. Hussain (2020)
10.3389/fchem.2020.00600
New Roadmaps for Non-muscle-invasive Bladder Cancer With Unfavorable Prognosis
Katia Pane (2020)
10.1007/s00261-018-1660-7
Radiomics and radiogenomics of prostate cancer
Clayton P Smith (2018)
10.1007/s11307-020-01487-8
Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms
Isaac Shiri (2020)
10.1038/s41598-019-46286-6
Radiogenomics-based cancer prognosis in colorectal cancer
B. Badic (2019)
10.1007/s11547-017-0833-8
Haralick’s texture features for the prediction of response to therapy in colorectal cancer: a preliminary study
D. Caruso (2017)
10.1016/J.SURONC.2019.06.006
Texture analysis parameters derived from T1-and T2-weighted magnetic resonance images can reflect Ki67 index in soft tissue sarcoma.
H. Meyer (2019)
10.3390/cancers12040866
Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study
H. I. Lee (2020)
10.1016/j.crad.2019.06.024
Texture analysis of multi-phase MRI images to detect expression of Ki67 in hepatocellular carcinoma.
Y. Li (2019)
10.1007/s00259-018-4010-7
Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study
M. Incoronato (2018)
10.1186/s41747-019-0143-0
Integrating radiomics into holomics for personalised oncology: from algorithms to bedside
Roberto Gatta (2020)
10.1177/1724600819899665
Correlating imaging parameters with molecular data: An integrated approach to improve the management of breast cancer patients
M. Incoronato (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar